Live on Bloomberg TVIs Anything Else Is Impacting Valeant Besides Brexit?On "Focus on Pharma," Bloomberg's Drew Armstrong reports on the impact Brexit may have on Valeant Pharmaceuticals. He speaks with Vonnie Quinn on "Bloomberg Markets." (Source: Bloomberg)More From Bloomberg Markets50:10Bloomberg Markets: Asia 04/26/20243 hours ago00:26Bank of Japan Holds Rates, Drops Bond Buying Reference Figure5 hours ago44:50Balance of Power 04/25/248 hours ago02:09Supreme Court Weighs Trump Immunity Case9 hours agoAll episodes and clipsThe David Rubenstein ShowThe David Rubenstein Show: Peer-to-Peer Conversations" explores successful leadership through the personal and professional choices of the most influential people in business.More episodes and clips23:36The David Rubenstein Show: Thomas Buberl24:06The David Rubenstein Show: Vas NarasimhanSee all shows